Cite
HARVARD Citation
Yang, C. et al. (2021). Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients. Clinical pharmacology & therapeutics. 109 (3), pp. 772-781. [Online].